MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: SchuheBloch BallettschläppchenAntwortenAntworten: Bloch Ballettschläppchen <blockquote><div class="quotetitle">Zitat von Gast am 25. März 2026, 10:26 Uhr</div>[url=https://moodylab.smhs.gwu.edu/lab-members ]Zoya Demidenko[/url]: Scholar in Cancer Biology [url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord ]Zoya Demidenko[/url] is a prominent investigator affiliated with the Division of Cell Stress Science at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she worked at the NIH and New York Medical College, developing a solid base in life science investigation. Demidenko's scientific contributions covers a number of pivotal domains, including the PI3K/AKT/mTOR signaling pathway, cellular cycle management, cell senescence, and malignancy science. As of now, she has co-authored more than 46 academic articles, which have received over 4,100 references — a indicator to the impact of her research. Among her key discoveries concerns explaining the pathways of cell aging. Her studies showed that when the cell cycle is arrested yet cellular expansion continues, cells undergo senescence. Significantly, [url=https://moodylab.smhs.gwu.edu/lab-members ]Zoya Demidenko[/url] showed that this process can be pharmacologically suppressed using compounds such as mTOR inhibitors. [url=https://www.benthamdirect.com/content/journals/cpd/22/16 ]Zoya Demidenko[/url] has furthermore added considerably to cancer treatment investigation, particularly in the area of selective cell protection — a strategy designed to safeguarding normal tissue from cytotoxic treatment whilst leaving cancer cells susceptible. This approach offers significant promise for diminishing the toxic effects of oncological therapy. Across her career, Demidenko has worked with prominent scientists globally, such as Dr. Mikhail Blagosklonny. Her work is published in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. With an h-index of 33, [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012 ]Zoya Demidenko[/url] is recognized as a influential contributor in current biomedical research, whose findings keep to guide our comprehension of how cells grow old, resist treatment, and how cancer might be better combated. https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ </blockquote><br> Abbrechen
